More research needed into the safest and most effective treatment for varicoceles in men affected by subfertility

More research needed into the safest and most effective treatment for varicoceles in men affected by subfertility

Vanessa Jordan
PEARLS No.
676
Clinical question

Clinical question Are surgical and radiological treatments for varicoceles in men with subfertility safe and effective?

Bottom line

Any treatment (surgical or radiologi­cal) may be more effective in increasing pregnancy rates than delayed or no treatment. Although both surgical and radiological treatments each improved pregnancy rates in participants with abnormal se­men parameters and clinical varicocele, it is not yet clear if this translates into increased live birth rates.

When comparing surgical with radiological treat­ment, no valid conclusions could be drawn on which treatment modality was superior. The evidence on varicocele recurrence and adverse events (hydrocele formation, pain, epididymitis, haematoma and su­ture granuloma) was also inconclusive. Evidence on quality of life was lacking for this comparison.

When comparing surgical treatments with each other, microscopic subinguinal surgical treatment showed higher pregnancy rates and lower varicocele recurrence rates than other surgical treatments.

Caveat

The clinical and statistical heterogeneity of the studies and the small numbers of participants should be taken into account. The overall certainty of the evidence was rated mostly as low or very low for all outcomes.

Context

Varicoceles are associated with male sub­fertility; however, the mechanisms by which vari­coceles affect fertility have yet to be satisfactorily explained. Several treatment options exist for var­icoceles, including surgical or radiological treat­ment; however, the safest and most efficient treatment remains unclear.

Cochrane Systematic Review

Cochrane Systematic Review Persad E, O’Lough­lin CA, Kaur S, et al. Surgical or radiological treat­ment for varicoceles in subfertile men. Cochrane Database Syst Rev 2021;4:CD000479. This review contains 48 trials with a total of 5384 participants.